About 8 results
Open links in new tab
Syros Pharmaceuticals Presents Data Demonstrating Significant Anti ...
The data presented at AACR shows that the RARA biomarker discovered by Syros is predictive of response to treatment with SY-1425 in AML cell lines and patient-derived xenograft (PDX) models of …
Syros to Host Virtual Event to Discuss Initial SELECT-AML-1 Data and ...
Participants can register for the event here. In addition, a live webcast of the presentation will be available on the Investors & Media section of the Syros website at www.syros.com. An archived …
Syros Announces Proposed Concurrent Public Offerings of Common …
Syros is pioneering the understanding of the non-coding regulatory region of the genome to advance a new wave of medicines that control the expression of genes.